APA (7th ed.) Citation

Shokri-Afra, H., Moghadam, S., Oladi, Z., Lotfizadeh, M., Mirforoughi, M. M., Arjmand, M., & Raeisi, A. (2025). Atorvastatin Attenuated the Inflammatory Outcomes of COVID-19: A Double-Blind, Randomized Controlled Trial. Journal of Reports in Pharmaceutical Sciences, 13(1), 1. https://doi.org/10.5812/jrps-149927

Chicago Style (17th ed.) Citation

Shokri-Afra, Hajar, Shahab Moghadam, Ziaeddin Oladi, Masoud Lotfizadeh, Mohammad Mehdi Mirforoughi, Mohammad-Hassan Arjmand, and Ahmad Raeisi. "Atorvastatin Attenuated the Inflammatory Outcomes of COVID-19: A Double-Blind, Randomized Controlled Trial." Journal of Reports in Pharmaceutical Sciences 13, no. 1 (2025): 1. https://doi.org/10.5812/jrps-149927.

MLA (9th ed.) Citation

Shokri-Afra, Hajar, et al. "Atorvastatin Attenuated the Inflammatory Outcomes of COVID-19: A Double-Blind, Randomized Controlled Trial." Journal of Reports in Pharmaceutical Sciences, vol. 13, no. 1, 2025, p. 1, https://doi.org/10.5812/jrps-149927.